172 related articles for article (PubMed ID: 11090155)
21. Identification of a T-helper cell epitope on the rotavirus VP6 protein.
Baños DM; Lopez S; Arias CF; Esquivel FR
J Virol; 1997 Jan; 71(1):419-26. PubMed ID: 8985366
[TBL] [Abstract][Full Text] [Related]
22. Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection.
Choi AH; Smiley K; Basu M; McNeal MM; Shao M; Bean JA; Clements JD; Stout RR; Ward RL
Vaccine; 2007 Apr; 25(16):3215-8. PubMed ID: 17280754
[TBL] [Abstract][Full Text] [Related]
23. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
24. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
25. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
[TBL] [Abstract][Full Text] [Related]
26. Induction of immune responses and partial protection in mice after skin immunization with rotavirus VP6 protein and the adjuvant LT(R192G).
Choi AH; Smiley K; Basu M
Vaccine; 2005 Mar; 23(17-18):2290-3. PubMed ID: 15755613
[TBL] [Abstract][Full Text] [Related]
27. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
[TBL] [Abstract][Full Text] [Related]
28. Deletion mapping of functional domains in the rotavirus capsid protein VP6.
Affranchino JL; González SA
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1949-55. PubMed ID: 9266993
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization.
Lopez-Guerrero DV; Arias N; Gutierrez-Xicotencatl L; Chihu-Amparan L; González A; Pedroza-Saavedra A; Rosas-Salgado G; Villegas-Garcia JC; Badillo-Godinez O; Fernandez G; Lopez S; Esquivel-Guadarrama F
Vaccine; 2018 May; 36(22):3072-3078. PubMed ID: 28465094
[TBL] [Abstract][Full Text] [Related]
30. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
O'Neal CM; Clements JD; Estes MK; Conner ME
J Virol; 1998 Apr; 72(4):3390-3. PubMed ID: 9525668
[TBL] [Abstract][Full Text] [Related]
31. The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice.
Pastor AR; Rodríguez-Limas WA; Contreras MA; Esquivel E; Esquivel-Guadarrama F; Ramírez OT; Palomares LA
Vaccine; 2014 May; 32(24):2874-7. PubMed ID: 24583002
[TBL] [Abstract][Full Text] [Related]
32. Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model.
Temprana CF; Argüelles MH; Gutierrez NM; Barril PA; Esteban LE; Silvestre D; Mandile MG; Glikmann G; Castello AA
PLoS One; 2018; 13(9):e0203700. PubMed ID: 30192869
[TBL] [Abstract][Full Text] [Related]
33. Localization of group-specific epitopes on the major capsid protein of group A rotavirus.
Kohli E; Maurice L; Vautherot JF; Bourgeois C; Bour JB; Cohen J; Pothier P
J Gen Virol; 1992 Apr; 73 ( Pt 4)():907-14. PubMed ID: 1378880
[TBL] [Abstract][Full Text] [Related]
34. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus.
Ijaz MK; Attah-Poku SK; Redmond MJ; Parker MD; Sabara MI; Frenchick P; Babiuk LA
J Virol; 1991 Jun; 65(6):3106-13. PubMed ID: 1851871
[TBL] [Abstract][Full Text] [Related]
35. Mapping the subgroup epitopes of rotavirus protein VP6.
López S; Espinosa R; Greenberg HB; Arias CF
Virology; 1994 Oct; 204(1):153-62. PubMed ID: 7522369
[TBL] [Abstract][Full Text] [Related]
36. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.
Garaicoechea L; Olichon A; Marcoppido G; Wigdorovitz A; Mozgovoj M; Saif L; Surrey T; Parreño V
J Virol; 2008 Oct; 82(19):9753-64. PubMed ID: 18632867
[TBL] [Abstract][Full Text] [Related]
37. Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring.
Coste A; Cohen J; Reinhardt M; Kraehenbuhl JP; Sirard JC
Vaccine; 2001 Jul; 19(30):4167-74. PubMed ID: 11457542
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles.
Frenchick PJ; Sabara MI; Ready KF; Babiuk LA
Vaccine; 1992; 10(11):783-91. PubMed ID: 1332271
[TBL] [Abstract][Full Text] [Related]
39. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.
Schwartz-Cornil I; Benureau Y; Greenberg H; Hendrickson BA; Cohen J
J Virol; 2002 Aug; 76(16):8110-7. PubMed ID: 12134016
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
Feng N; Lawton JA; Gilbert J; Kuklin N; Vo P; Prasad BV; Greenberg HB
J Clin Invest; 2002 May; 109(9):1203-13. PubMed ID: 11994409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
